Elevated domestic cyclosporiasis incidence is driving trader focus, with CDC reporting 10,468 laboratory-confirmed U.S.-acquired cases from May 1 through August 3, 2026—substantially above the 249 recorded in the same 2025 interval—plus thousands more under investigation. The surge stems primarily from multistate outbreaks tied to contaminated iceberg lettuce imported from central Mexico, prompting recalls and affecting 15 states with links to specific supply chains. Cyclospora cayetanensis transmission occurs via fecal-oral route in produce, with underdiagnosis common due to nonspecific symptoms and limited testing; cases typically peak May–August. Weekly CDC surveillance updates and ongoing FDA traceback investigations through late August could refine totals before the August 31 cutoff, though historical underreporting introduces uncertainty in final counts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCyclosporiasis cases in U.S. by August 31?
15,000+
91%
20,000+
49%
$2,682 Vol.
15,000+
91%
20,000+
49%
The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Market Opened: Jul 27, 2026, 11:16 PM ET
Resolver
0x65070BE91...The resolution source for this market will be the CDC Surveillance of Cyclosporiasis page’s “U.S. cases reported to CDC” count (see: https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC as confirmed domestically acquired cases of cyclosporiasis will qualify, regardless of reports from U.S. State agencies or other sources. Travel-associated cases acquired outside the United States will not qualify.
Resolver
0x65070BE91...Elevated domestic cyclosporiasis incidence is driving trader focus, with CDC reporting 10,468 laboratory-confirmed U.S.-acquired cases from May 1 through August 3, 2026—substantially above the 249 recorded in the same 2025 interval—plus thousands more under investigation. The surge stems primarily from multistate outbreaks tied to contaminated iceberg lettuce imported from central Mexico, prompting recalls and affecting 15 states with links to specific supply chains. Cyclospora cayetanensis transmission occurs via fecal-oral route in produce, with underdiagnosis common due to nonspecific symptoms and limited testing; cases typically peak May–August. Weekly CDC surveillance updates and ongoing FDA traceback investigations through late August could refine totals before the August 31 cutoff, though historical underreporting introduces uncertainty in final counts.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions